Home › NDC Lookup › RxCUI directory › RxCUI 979543

24 HR phendimetrazine tartrate 105 MG Extended Release Oral Capsule — RxCUI 979543

RxNorm drug concept · Semantic clinical drug
RxCUI 979543 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI979543
Official name24 HR phendimetrazine tartrate 105 MG Extended Release Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asphendimetrazine 105 MG 24 HR Extended Release Oral Capsule; phendimetrazine tartrate 105 MG 24HR Extended Release Oral Capsule
FDA products mapped1
Package NDCs mapped1
Reported Medicaid activity (SDUD)104 prescriptions · 1 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Phendimetrazine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Phendimetrazine is a short-term prescription aid to help you lose weight when diet and exercise alone haven't been enough. It's a stimulant that works on your central nervous syste...
  • What exactly is phendimetrazine supposed to do for me?
  • It depends on which form you have. If you have the tablet, you'll generally take it about an hour before meals, two or three times a day. If you have the extended-release capsule,...
  • How do I take it — does it matter when during the day?
📖 Read our full Phendimetrazine guide →

🕸️ Concept Web — How 24 HR phendimetrazine tartrate 105 MG Extended R... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 24 HR phendimetrazine tartrate 105 MG Extended Release Oral Capsule RxCUI 979543

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Phendimetrazine 33272
    • Phendimetrazine tartrate 58157
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Melfiat 224912
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Phendimetrazine Extended Release Oral Capsule 373305
    • Phendimetrazine tartrate Extended Release Oral Capsule 2648177
    • Phendimetrazine Oral Product 1161974
    • Phendimetrazine Pill 1161975
    • Phendimetrazine tartrate Oral Product 2660088
    • Phendimetrazine tartrate Pill 2662108
    • Phendimetrazine Extended Release Oral Capsule [Melfiat] 366842
    • Phendimetrazine tartrate Extended Release Oral Capsule [Melfiat] 2657090
    • +5 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Phendimetrazine tartrate 105 MG 979542
    • 24 HR phendimetrazine tartrate 105 MG Extended Release Oral Capsule [Melfiat] 994071
    • Phendimetrazine tartrate 105 MG [Melfiat] 994070

Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Phendimetrazine tartrate 105 MG SCDC · 979542
  • Phendimetrazine Extended Release Oral Capsule SCDF · 373305
  • Phendimetrazine tartrate Extended Release Oral Capsule SCDFP · 2648177
  • Phendimetrazine Oral Product SCDG · 1161974
  • Phendimetrazine Pill SCDG · 1161975
  • Phendimetrazine tartrate Oral Product SCDGP · 2660088
  • Phendimetrazine tartrate Pill SCDGP · 2662108

Brand-Name Concepts

  • 24 HR phendimetrazine tartrate 105 MG Extended Release Oral Capsule [Melfiat] SBD · 994071
  • Phendimetrazine tartrate 105 MG [Melfiat] SBDC · 994070
  • Phendimetrazine Extended Release Oral Capsule [Melfiat] SBDF · 366842
  • Phendimetrazine tartrate Extended Release Oral Capsule [Melfiat] SBDFP · 2657090
  • Melfiat Oral Product SBDG · 1183816
  • Melfiat Pill SBDG · 1183817
  • Melfiat BN · 224912

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 979543 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
72989-0409-30 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (72989-409-30) PHENDIMETRAZINE TARTRATE Acertis Pharmaceuticals, LLC 2022-11-01
Observed labelers: Acertis Pharmaceuticals, LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ea · median
$3.2191
Range $3.2191–$3.2191 · middle 50% $3.2191–$3.2191 · 1 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.